TLSA Company Profile and Key Details

Q: Who are the executives of TLSA?

Dr. Napoleone Ferrara M.D.Member of Scientific Advisory BoardDr. Andrea BrancaleScientific FounderMr. Richard Clarkson Ph.D.Scientific FounderProf. Roberto Pellicciari Ph.D.ConsultantMr. Andrew Westwell Ph.D.Scientific FounderProf. Napoleone Ferrara M.D.Member of Scientific Advisory BoardDr. Matthew W. Davis M.D., R.Ph., RPhChief Operating Officer & Chief Medical OfficerDr. Matthew W. Davis M.D., RPhChief Operating Officer, Chief Medical Officer & Acting Chief Scientific Officer

NASDAQ : TLSA

Tiziana Life Sciences

$1.54

-0.0084-0.54%

Open: 11:46 AM

63.64

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Tiziana Life Sciences Ltd (TLSA) stock declined over -0.54%, trading at $1.54 on NASDAQ, down from the previous close of $1.55. The stock opened at $1.59, fluctuating between $1.52 and $1.60 in the recent session.

Stock Snapshot

1.55

Prev. Close

91.61M

Market Cap

1.5157

Day Low

-11.86

P/E Ratio

-0.13

EPS (TTM)

-0.08

Cash Flow per Share

1.59

Open

59.43M

Number of Shares

1.6

Day High

55.81%

Free Float in %

0.13

Book Value

59.57K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Dec 29, 2025	1.50	1.60	1.48	1.55	187.94K
Dec 26, 2025	1.56	1.58	1.47	1.48	101.55K
Dec 24, 2025	1.50	1.56	1.46	1.53	211.61K
Dec 23, 2025	1.54	1.55	1.45	1.46	188.65K
Dec 22, 2025	1.54	1.60	1.50	1.54	208.32K
Dec 19, 2025	1.45	1.62	1.36	1.52	480.43K
Dec 17, 2025	1.51	1.60	1.39	1.46	382.08K
Dec 16, 2025	1.54	1.58	1.45	1.55	252.31K
Dec 15, 2025	1.79	1.81	1.30	1.59	2.25M
Dec 12, 2025	1.71	1.80	1.59	1.78	957.84K
Dec 11, 2025	1.76	1.82	1.70	1.72	135.4K
Dec 10, 2025	1.73	1.80	1.70	1.80	162.45K
Dec 09, 2025	1.68	1.75	1.62	1.73	341.92K
Dec 08, 2025	1.71	1.74	1.65	1.67	215.3K
Dec 05, 2025	1.74	1.78	1.69	1.74	157.83K
Dec 04, 2025	1.69	1.80	1.62	1.77	208.46K
Dec 03, 2025	1.78	1.81	1.63	1.69	389.06K
Dec 02, 2025	1.77	1.90	1.66	1.79	683.92K
Dec 01, 2025	1.79	1.84	1.76	1.79	348.64K
Nov 28, 2025	1.81	1.88	1.74	1.80	79.99K

Contact Details

London, W1K 1NA

United Kingdom

https://www.tizianalifesciences.com 442 074 952379

About Company

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), a small molecule inhibitor of various cyclin-dependent kinases, tropomycin receptor kinases, and Src family kinases controlling cell growth and malignant progression of cancer; and anti-Interleukin 6 receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody for the treatment of IL6-induced inflammation and to treat COVID-19 patients. The company was incorporated in 1998 and is headquatered in London, the United Kingdom.

Stock Peers

ARGX

-7.47-0.88%

argenx SE$837.45 REGN

-4.47-0.57%

Regeneron Pharmaceuticals, Inc.$780.50 MDGL

-9.44-1.58%

Madrigal Pharmaceuticals, Inc.$589.47 UTHR

-4.26-0.84%

United Therapeutics Corporation$502.90 VRTX

-3.12-0.67%

Vertex Pharmaceuticals Incorporated$459.78 ALNY

-1.77-0.44%

Alnylam Pharmaceuticals, Inc.$398.82 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

35.63+13.25%

Praxis Precision Medicines, Inc.$304.58 KRYS

1.51+0.60%

Krystal Biotech, Inc.$253.68 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Frequently Asked Questions

What is the current Tiziana Life Sciences Ltd (TLSA) stock price?

Tiziana Life Sciences Ltd (NASDAQ: TLSA) stock price is $1.54 in the last trading session. During the trading session, TLSA stock reached the peak price of $1.60 while $1.52 was the lowest point it dropped to. The percentage change in TLSA stock occurred in the recent session was -0.54% while the dollar amount for the price change in TLSA stock was - $0.01.

TLSA's industry and sector of operation?

The NASDAQ listed TLSA is part of Biotechnology industry that operates in the broader Healthcare sector. Tiziana Life Sciences Ltd designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of TLSA?

Dr. Napoleone Ferrara M.D.
Member of Scientific Advisory Board
Dr. Andrea Brancale
Scientific Founder
Mr. Richard Clarkson Ph.D.
Scientific Founder
Prof. Roberto Pellicciari Ph.D.
Consultant
Mr. Andrew Westwell Ph.D.
Scientific Founder
Prof. Napoleone Ferrara M.D.
Member of Scientific Advisory Board
Dr. Matthew W. Davis M.D., R.Ph., RPh
Chief Operating Officer & Chief Medical Officer
Dr. Matthew W. Davis M.D., RPh
Chief Operating Officer, Chief Medical Officer & Acting Chief Scientific Officer

How TLSA did perform over past 52-week?

TLSA's closing price is 146.03% higher than its 52-week low of $0.63 where as its distance from 52-week high of $2.60 is -40.38%.

How many employees does TLSA have?

Number of TLSA employees currently stands at 9.

Link for TLSA official website?

Official Website of TLSA is: https://www.tizianalifesciences.com

How do I contact TLSA?

TLSA could be contacted at phone 442 074 952379 and can also be accessed through its website. TLSA operates from 55 Park Lane, London, W1K 1NA, United Kingdom.

How many shares of TLSA are traded daily?

TLSA stock volume for the day was 59.57K shares. The average number of TLSA shares traded daily for last 3 months was 319.93K.

What is the market cap of TLSA currently?

The market value of TLSA currently stands at $91.61M with its latest stock price at $1.54 and 59.43M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	9
Beta	0.23
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	9
Beta	0.23
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

TLSA Company Profile and Key Details

Tiziana Life Sciences

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Company Overview

Technical Performance

Earnings & Analyst Outlook

Shareholding & Insider Activity

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Key Takeaways

Price Forecast & Outlook